With many articles covering the facts or even the looming uncertainty concerning the Sunshine Act, it was nice to come across an article that could see the silver lining in the cloudy post-sunshine days. The article, “The Bright Side of the Sunshine Act” mentions some of the pros of the Final Rule on the Sunshine Act. Where is the silver lining?
For background, the Physician Payment Sunshine Act is part of the Patient Protection and Affordable Act. The Sunshine Act requires medical device, pharmaceutical and similar companies to report any payment or other transfer of value to the Health and Human Services (HHS). These are intended to give the public easier access to information on healthcare providers and their financial ties to companies in order to decrease any underlying or potential bias. The goal of this disclosure is to not only increase transparency, but also equip patients with the knowledge of financial interests creating better informed patients. Already seeing a silver lining?
The article also points out that “when the data is captured appropriately, there is value in it. With a greater, more wholesome view of your interactions with Healthcare Professionals (HCPs) and any spend associated with those interactions, you will be able to detect and resolve issues that raise red flags and compliance concerns.”
The silver lining can be seen in the forms of:
- Increased Transparency
- Better informed public
- Unbiased treatment
At the very least, this Act will help provide more transparency and public knowledge surrounding money and payments regarding those products in clinical trials. Hopefully this will further make all parties aware of their accountability to patients and to conduct research in the highest ethics in all aspects of a clinical trial.
Do you see any more benefits to the Sunshine Act? Or do you forecast stormy days ahead? Feel free to leave your thoughts below.
Photo Credit: mattyp